MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Genomic Health Company Profile (NASDAQ:GHDX)

Consensus Ratings for Genomic Health (NASDAQ:GHDX) (?)
Ratings Breakdown: 1 Sell Rating(s), 2 Hold Rating(s), 6 Buy Rating(s)
Consensus Rating:Buy (Score: 2.56)
Consensus Price Target: $35.14 (26.46% upside)

Analysts' Ratings History for Genomic Health (NASDAQ:GHDX)
Show:
DateFirmActionRatingPrice TargetActions
1/20/2016Leerink SwannReiterated RatingOutperform$38.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/11/2016Piper JaffrayDowngradeOverweight -> Neutral$36.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2016BarclaysReiterated RatingSellView Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2016Cowen and CompanyBoost Price Target$40.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/7/2016BarclaysBoost Price TargetUnderweight$25.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/6/2016Canaccord GenuityUpgradeHold -> Buy$26.00 -> $44.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/19/2015Cowen and CompanyUpgradeMarket Perform -> Outperform$27.00 -> $35.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/16/2015Canaccord GenuityReiterated RatingHold$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/4/2015Raymond JamesUpgradeMarket Perform -> Outperform$29.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/2/2015JMP SecuritiesBoost Price TargetOutperform$34.00 -> $36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/2/2015Canaccord GenuityLower Price TargetHold$30.00 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
10/14/2015Cowen and CompanyLower Price TargetMarket Perform$31.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/2/2015BarclaysInitiated CoverageUnderweight$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/28/2015Raymond JamesUpgradeUnderperform -> Market PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/5/2015Canaccord GenuityReiterated RatingHold$28.00 -> $26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/28/2015Credit SuisseReiterated RatingNeutralView Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015JMP SecuritiesLower Price TargetMarket Outperform$36.00 -> $33.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/6/2015Canaccord GenuityReiterated RatingHold$28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2015William BlairReiterated RatingOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2015JMP SecuritiesBoost Price TargetMarket Outperform$34.00 -> $36.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/11/2015Canaccord GenuitySet Price TargetHold$28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/19/2014Wells FargoInitiated CoverageMarket PerformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/7/2014Credit SuisseReiterated RatingNeutral$28.00 -> $32.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2014Canaccord GenuityReiterated RatingHold$27.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/5/2014Bank of AmericaReiterated RatingBuy$28.00 -> $30.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2014Canaccord GenuityReiterated RatingHold$30.00 -> $27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
5/7/2014JPMorgan Chase & Co.Reiterated RatingNeutral$29.00 -> $28.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/8/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha